A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.
There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago.
“It is the first ever to show antiviral activity against dengue,” Marnix Van Loock, who oversees emerging pathogens research for J&J’s Janssen division, said of the drug.
In human challenge trials, researchers intentionally expose healthy volunteers to a pathogen to test a vaccine or treatment, or better understand the disease they cause.
Dengue fever, while often asymptomatic, is also known as “break bone fever” for the severity of the joint pain and spasms that some patients experience. It has long been a scourge across much of Asia and Latin America, causing millions of infections each year and tens of thousands of deaths, and is likely to spread further as climate change makes more areas hospitable for the mosquitoes that spread it, the World Health Organization’s chief scientist Jeremy Farrar said earlier this month.
In the trial done with Johns Hopkins Bloomberg School of Public Health, 10 volunteers were given a high dose of the J&J pill five days before being injected with a type of dengue. They continued to take the pill for 21 days afterwards.
Six of the 10 showed no detectable dengue virus in their blood after being exposed to the pathogen, as well as no signs that their immune system had responded to infection by the virus over 85 days of monitoring.
The five people in a placebo group, who were also injected with dengue, all showed detectable virus when tested. Trial participants received standard care from medical professionals where necessary, and the virus used was a weakened version to minimise symptoms.
The positive early data supports ongoing Phase II trials of the pill to prevent the four different types of dengue in a real world-setting where the disease is common, J&J said. The next step will be testing it as a treatment.
The drug works by blocking the action of two viral proteins, preventing the virus from making copies of itself. It was well-tolerated by all trial participants, J&J said.
A key question for the future will be ensuring access to the new drug, if it works on a larger scale, in many of the low- and middle-income countries where it is most needed, an echo of the challenge for the dengue vaccine the WHO backed earlier this month.
“We’re working on it,” said Van Loock, adding that it was early days.
Reuters
Fri Oct 20 2023
The positive early data supports ongoing Phase II trials of the pill to prevent the four different types of dengue in a real world-setting where the disease is common, Johnson & Johnson said. - REUTERS/Filepic
Rakyat Israel desak kerajaan bawa pulang tebusan yang tinggal
Ribuan berkumpul di Tel Aviv pada Sabtu malam bagi mendesak kerajaan Israel mencapai perjanjian gencatan senjata dengan Hamas dan membawa pulang tebusan yang tinggal
Hamas keluarkan video dua tebusan Israel
Kumpulan pejuang Hamas mengedarkan video menampilkan dua tahanan Israel yang menyeru kepada Perdana Menteri Israel, Benjamin Netanyahu, untuk memenuhi perjanjian pembebasan mereka.
Israel sedia tangguh serangan ke atas Rafah
Israel bersedia menangguhkan serangan ke Rafah jika perjanjian pembebasan tahanan Hamas tercapai. Menteri Luar Israel, Israel Katz, menegaskan keutamaan pembebasan tahanan.
Restoran nasi kandar dibaling cat, polis kesan tiga lelaki
Cat merah tersebut terkena papan tanda dan pintu hadapan restoran yang mula beroperasi pada Sabtu.
Kawasan Beris Lalang terbakar lagi
Cuaca panas melampau di Kelantan menyebabkan kebakaran ladang dan semak di kawasan Beris Lalang. Penduduk dan pekebun mengalami kerugian
Ringgit dijangka diniaga dalam jajaran kecil
Ringgit Malaysia dijangka berada di sekitar 4.77 berbanding Dolar AS minggu depan, bergantung kepada keputusan FOMC dan data ekonomi AS
Bursa Malaysia dijangka diniagakan dalam jajaran kecil
Analisis terkini menunjukkan Bursa Malaysia berpotensi naik dalam jajaran kecil minggu depan, dengan pandangan positif terhadap kembalinya dana asing. Paras sokongan dan konsolidasi disebutkan.
PM tiba di Riyadh untuk hadiri mesyuarat WEF
Datuk Seri Anwar Ibrahim tiba di Riyadh bagi menghadiri Mesyuarat Khas Forum Ekonomi Sedunia. Beliau dijadual terlibat dalam dialog strategik, panel, dan pertemuan bersama pemimpin serantau
Battle Of The Reds: Legenda Liverpool masih bertenaga
Legenda Manchester United terpaksa akur dengan kekalahan kepada legenda Liverpool dengan jaringan 4-2.
Boling Padang: Farah Ain muncul juara dunia!
Farah pamer aksi luar biasa dalam penampilan sulungnya di pentas bertaraf dunia dengan kemenangan straight sets 6-2 dan 6-3.
Awas! Empat krisis dunia ini dikhuatiri jadi lebih buruk akibat COVID-19
Selain menyebabkan kematian dan kerugian besar kepada ekonomi, ia juga boleh menyebabkan krisis berkaitan kemanusiaan menjadi bertambah buruk.
Climate change in Malaysia and what it means for us
The worlds climate is changing for the worse, and humans are responsible for that. Lets dive into a touch of science to make sense of this.
Demam denggi menurun kepada 1,300 kes minggu lepas - Subramaniam
Penurunan sebanyak 1,200 kes itu berikutan pelbagai usaha Kementerian Kesihatan dalam mengawal pembiakan nyamuk Aedes terutama di kawasan berisiko.
CukupSetakatSamson: Isteri Allahyarham pesan agar masyarakat tidak leka
Zamila Razeman, 27, turut mengingatkan masyarakat supaya tidak mengambil mudah kerana demam panas melampau termasuk dalam simptom denggi yang boleh membawa maut.